Tom Parker speaks about his cancer treatment in 2021 We use your sign-up to provide content in ways you’ve consented to and to improve our…
Home » Health News »
Stroke, heart failure death rates accelerating in some Hispanic adults
Scientists debate whether Hispanic adults, who have higher rates of certain risk factors for cardiovascular disease, are nonetheless less likely to die from it than…
Case study of multi-system inflammatory syndrome in children in a fully vaccinated teenager
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has circulated worldwide since December 2019, causing millions of deaths. Newer variants have emerged in quick succession…
How to keep children safe from window falls
Each year, about eight children ages five or younger die and 3,300 require emergency treatment after falling from windows, according to the Consumer Product Safety…
Improving diagnosis of asthma-COPD overlap
A University of Texas at Arlington faculty member and nurse practitioner (NP) said she hopes to bring more attention to an underrecognized condition. Lynda Jarrell,…
Pandemic ‘shielding’ led to two-fold rise in depressive symptoms in over-50s
Older people who were shielding throughout the pandemic were nearly twice as likely to experience depressive symptoms compared to those who were not, even after…
New heart failure guidelines expand focus on people at risk or showing early signs
A new set of recommendations aimed at helping doctors prevent and manage heart failure expand the focus on people at risk or showing early signs…
Billions of people still breathe unhealthy air, WHO says
How nearly ALL of the world is breathing dirty air: 99% per cent of Earth’s 7BILLION population lives in areas where pollution exceeds safe limits,…
Consensus document offers recommendations on genetic testing for inherited cardiac diseases
When should patients and family members undergo genetic assessment for a heart condition? Find out in an international consensus document published in EP Europace, a…
Mavacamten Controlled Hypertrophic Cardiomyopathy for >1 Year
WASHINGTON – Treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy who remained on treatment with the investigational agent mavacamten for a median of 62 weeks continued…